Expected late-stage reduction under extended screening in the first multicancer screening trial

Kemal Caglar Gogebakan, Jane Lange, Roman Gulati, Ruth Etzioni

Open source

DOI
10.1158/1055-9965.epi-26-0942
Published
2026-09-16
Container
Cancer Epidemiology, Biomarkers & Prevention
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1055-9965.epi-26-0942,
  title = {Expected late-stage reduction under extended screening in the first multicancer screening trial},
  author = {Kemal Caglar Gogebakan and Jane Lange and Roman Gulati and Ruth Etzioni},
  year = {2026},
  journal = {Cancer Epidemiology, Biomarkers \& Prevention},
  doi = {10.1158/1055-9965.epi-26-0942},
  url = {https://doi.org/10.1158/1055-9965.epi-26-0942}
}

RIS

TY  - JOUR
TI  - Expected late-stage reduction under extended screening in the first multicancer screening trial
AU  - Kemal Caglar Gogebakan
AU  - Jane Lange
AU  - Roman Gulati
AU  - Ruth Etzioni
PY  - 2026
JO  - Cancer Epidemiology, Biomarkers & Prevention
DO  - 10.1158/1055-9965.epi-26-0942
UR  - https://doi.org/10.1158/1055-9965.epi-26-0942
ER  - 

APA

Gogebakan, K. C., Lange, J., Gulati, R., & Etzioni, R. (2026). Expected late-stage reduction under extended screening in the first multicancer screening trial. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-26-0942

Source records